Neurocrine Biosciences
NBIX
#1645
Rank
$8.79 B
Marketcap
$90.11
Share price
-1.22%
Change (1 day)
-3.62%
Change (1 year)
Neurocrine Biosciences is an American biopharmaceutical company that develops treatments for neurological and endocrine-related diseases and disorders.

Earnings for Neurocrine Biosciences (NBIX)

Earnings in 2023 (TTM): $94.8 M

According to Neurocrine Biosciences 's latest financial reports the company's current earnings (TTM) are $94.8 M. In 2022 the company made an earning of $0.22 B an increase over its 2021 earnings that were of $0.12 B.The earnings displayed on this page is the company's Pretax Income.

Earnings history for Neurocrine Biosciences from 2001 to 2023

Annual earnings

Year Earnings Change
2023 (TTM)$94.8 M-57.1%
2022$0.22 B73.74%
2021$0.12 B-8.82%
2020$0.13 B77.62%
2019$78.53 M49.96%
2018$52.37 M-142.02%
2017-$0.13 B-15.44%
2016-$0.15 B56.44%
2015-$94.21 M46.25%
2014-$64.42 M29.66%
2013-$49.68 M-3530.8%
2012$1.44 M-95.73%
2011$33.91 M
2009-$47.69 M-45.38%
2008-$87.3 M-58.87%
2007-$0.22 B87.3%
2006-$0.12 B351.97%
2005-$25.08 M-52.09%
2004-$52.34 M-10.98%
2003-$58.79 M-43.26%
2002-$0.11 B136.12%
2001-$43.89 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
$33.18 B 34,904.22%๐Ÿ‡บ๐Ÿ‡ธ USA
$9.02 B 9,417.93%๐Ÿ‡บ๐Ÿ‡ธ USA
$6.28 B 6,527.11%๐Ÿ‡บ๐Ÿ‡ธ USA
$0.19 B 108.27%๐Ÿ‡บ๐Ÿ‡ธ USA
-$77.01 M-181.23%๐Ÿ‡บ๐Ÿ‡ธ USA
-$34.61 M-136.50%๐Ÿ‡บ๐Ÿ‡ธ USA
-$34.72 M-136.62%๐Ÿ‡บ๐Ÿ‡ธ USA
$0.79 B 742.74%๐Ÿ‡ฌ๐Ÿ‡ง UK